Open AccessAnti-anxiety effect of a novel 5-HT 3 receptor antagonist N-(benzo[d]thiazol-2-yl)-3-ethoxyquinoxalin-2-carboxamide (6k) using battery tests for anxiety in mice
Author(s) -
YeshwantVijay Kurhe,
Mahesh Radhakrishnan,
Thangaraj Devadoss,
Deepali Gupta
Publication year - 2014
Publication title -
indian journal of pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.286
H-Index - 59
eISSN - 1998-3751
pISSN - 0253-7613
DOI - 10.4103/0253-7613.125186
Subject(s) - antagonist , open field , elevated plus maze , receptor antagonist , chemistry , receptor , endocrinology , medicine , anxiety , pharmacology , psychiatry
To investigate the anti-anxiety activity of "6k", a novel 5-hydroxytryptamine type 3 (5-HT₃) receptor antagonist in in mice.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom